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Abstract
To investigate the function of specificity protein 6 (SP6) transcription factor by gain-of-function procedure, we 
established cytomegalovirus (CMV) promoter-driven Sp6 stable transformants, C9 cells, using dental epithelial-
derived cells.  Initially, C9 cells produced a significant amount of SP6 protein. However, SP6 expression was 
reduced in these cells upon long-term culture. We could detect Sp6 transcripts in C9 cells by RT-PCR throughout 
the passages, although the CMV promoter is known to be epigenetically silenced. We recently found that SP6 
was a short-lived protein that was degraded by a ubiquitin-independent proteasome pathway, although it is 
yet unclear how Sp6 expression was regulated during culture. Thus, we studied the possibility of epigenetic 
regulation of Sp6 expression. Comparative analysis of endogenous and exogenous Sp6 mRNA expressions 
demonstrated the specific down-regulation of exogenous Sp6 mRNA levels during culture passages. A DNA 
methyltransferase inhibitor, 5-Aza-2'-deoxycytidine (5AC), and a histone deacetylase inhibitor, valproic acid 
(VPA), enhanced or induced SP6 protein expression up to passage 28 without enhancing the mRNA level. The 
dramatic up-regulation of exogenous Sp6 mRNA was uniquely observed only at passage 50 by 5AC or VPA 
treatment. These findings indicate that multiple epigenetic regulatory mechanisms operate to fine-tune Sp6 
expression during long-term culture.  
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1. Introduction 
Tooth development is a multistep process that 
is regulated by a combination of genetic and 
epigenetic information1,2. Numerous transcription 
factors have been identified that are involved in 
this developmental process3,4. Sp6, also known as 
epiprofin, was first identified in dental epithelial 
cells and belongs to the SP/KLF transcription 
factor family5-7. It is one of the critical molecules 
required for tooth development4,8, as Sp6 deficient-
mice show abnormal tooth phenotypes, such as 
delayed eruption of incisors, supernumerary teeth, 
or enamel disorganizations, in addition to other 
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abnormal tissue phenotypes, including hair loss, lung 
abnormalities, and limb deformities9,10. However, 
the molecular mechanisms underlying these Sp6-
deficient phenotypes remain unclear.
In a previous study, we found that overexpression 
of the Sp6 gene inhibited follistatin (Fst) gene 
expression in dental epithelial cells, suggesting that 
SP6 regulated tooth development by modulating 
bone morphogenetic protein (BMP) signaling11. We 
subsequently characterized the structure of the 
Sp6 gene and detected two alternative promoter 
activities in a cell-type specific manner in addition to 
a possible third promoter activity located between 
exon 1b and exon 2 in dental epithelial cells12. At 
the same time, we found that Sp6 expression was 
up-regulated by both BMP and Wnt signals, which 
provided a possible linkage between cytokine 
regulation of Sp6 expression and inductive epithelial–
mesenchymal interactions through a feedback loop 
involving BMP signaling during tooth development 
11-13. We also found that the SP6 protein is short-
lived and degraded by a ubiquitin-independent 
proteasome pathway14. These findings suggested 
that fine-tuning of Sp6 expression is required during 
tooth development.
In this study, we analyzed the epigenetic 
regulation of Sp6 gene expression in C9 cells treated 
with a DNA methyltransferase inhibitor (DNMTI), 
5AC15, and a histone deacetylase inhibitor (HDACI), 
VPA16. C9 is a Sp6 stable transformant clone that 
is driven by the cytomegalovirus (CMV) promoter. 
High SP6 protein expression in C9 cells was detected 
at passage 7 (P7) but not at P28 and P50. When 
we treated C9 cells with the epigenetic regulatory 
reagents, protein expression was enhanced or 
induced at P7 and P28 but not at P50.  In contrast, 
we found no enhancement of either exogenous or 
endogenous Sp6 mRNA at any cell passages, except 
for exogenous Sp6 mRNA at P50 after treatment with 
5AC and VPA, while Sp6 transcripts were detected 
throughout the cell passages. These findings suggest 
that the epigenetic status tightly regulates not only 
Sp6 gene expression but also SP6 protein expression 
in C9 cells during long-term culture. Our findings 
provide a new perspective for the regulation of the 
Sp6 mRNA and protein levels to understand the SP6 
function in tooth development. 
2. Materials and Methods
2.1 Cell line and culture conditions
The SP6 high producer CHA9 cells was origi nal ly 
established as described previously11. Briefly, an HA-
tagged SP6 coding sequence (CHA-Sp6) was inserted 
into a CMV promoter-driven ex pres sion plasmid. 
Then, the expression plasmid was transfected into 
dental epithelial, ameloblast lineage clone, G5 
cells17. CHA9 cells were selected by serial limiting 
dilutions in the presence of G418 (400 μg/ml: 
Nakalai Tesque, Kyoto, Japan) followed by Western 
blot analysis to identify the highest SP6 producer. C9 
cells were then recloned from CHA9 cells because 
SP6 expression was silenced. In the same manner 
as CHA9 cells, we performed serial limiting dilutions 
in the presence of G418 (400 μg/ml) and Western 
blot analysis to isolate a Sp6 high producer clone, 
which was designated as C9. For maintenance, 
these cells were cultured in a combination of 
Dulbecco’s modified Eagle’s medium/Ham’s F12 (D/
F12) medium, supplemented with 10% fetal bovine 
serum (JRH Biosciences, Lenexa, KS) and 400 µg/ml 
of G418.
2.2 Reagents
5AC and VPA were purchased from Sigma-Aldrich, 
Inc. (St. Louis, MO, USA) and Wako Pure Chemical 
Industries, Ltd. (Osaka, Japan), respectively. These 
reagents were added to cultures of C9 cells at 70% 
confluence and cultured for the indicated time.
2.3 Western Blot analysis
C9 cells were harvested and lysed in 2x sodium 
dodecyl sulfate (SDS) sample buffer as described 
previously 11. Protein concentration was determined 
using the BCA Protein Assay Kit (Pierce, Rockford, 
IL, USA). Total protein (30 µg) was loaded onto a 
10% SDS-polyacrylamide gel. After electrophoresis, 
proteins were transferred to a polyvinylidene 
difluoride (PVDF) membrane (ImmobilonTM; 
Millipore, Bedford, MA, USA) and blocked with 5% 
skim milk in tris-buffered saline (TBS: 10 mM Tris-
HCl, pH 8.0, 150 mM NaCl) with 0.05% Tween-20 
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for 3 hours at room temperature.  The membranes 
were incubated with an anti-HA antibody (1:5000; 
Santa Cruz Biotechnology, Santa Cruz, CA, USA) 
overnight, following which immunodetection was 
performed. Quantification of detected signals was 
performed by densitometric analysis using “Quantity 
One” software (Bio-Rad laboratories, Hercules, CA, 
USA) according to the manufacturer’s instructions. 
Lysates of Cos7 cells transfected with CHA-Sp6 in 
pCIneo were used as a positive control.
2.4 Reverse transcription-PCR (RT-PCR) and 
quanti tative RT-PCR analysis
Total RNA was isolated using TriReagent (Mole-
cular Research Center. Inc., Cincinnati, OH, USA) 
according to the manufacturer’s instructions.  After 
treatment with DNase I (Invitrogen, Carlsbad, CA, 
USA), 500 ng of total RNA was converted into cDNA 
using an RNA PCR kit AMV Ver.3.0 (Takara, Shiga, 
Japan) according to the manufacturer’s instructions. 
Synthesized cDNA was used for either PCR analysis 
using Taq DNA polymerase (Promega, Madison 
WI, USA) or quantitative RT-PCR (qRT-PCR) using 
THUNDERBIRDTM SYBR qPCR Mix (Toyobo Co. Ltd., 
Osaka, Japan). qRT-PCR was performed using a 7300 
Real-Time PCR system (Applied Biosystems, Carlsbad, 
CA, USA).  Expression level ratios were calculated 
from the threshold cycles and normalized to those 
of 18s rRNA levels. All results were confirmed by 
triplicate experiments. Gene specific primer sets are 
shown in Table 1.
2.5 Statistics
RT-PCR and qRT-PCR results are from three 
independent analyses performed under the same 
experimental conditions. Results are presented 
as means ±S.D. of triplicate samples for the 
representative experiments.
3. Results 
3.1 SP6 protein expression during long-term 
culture
To investigate the SP6 function, we originally established 
Sp6 stable transformant CHA9 cells11 using dental 
epithelial-derived G5 cells16. Unexpectedly, we found 
that the SP6 protein expression level was reduced in 
CHA9 cells during long-term culture. Therefore, we 
recloned a new SP6 high producer clone from CHA9 
cells, designated as C9 cells. At P28, we again found 
a significant reduction of SP6 protein expression in 
C9 cells compared with the high SP6 expression at 
P7 (Figure 1A).  
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Figure 1.  SP6 protein expression during long-term culture. 
(A) SP6 expression in C9 (P7, P28, and P50) and parental G5 
cells.  The levels of SP6 protein expression were analyzed by 
Western Blots using an anti-HA antibody.  Posi: positive 
control.  (B) Sp6 mRNA expression in C9 (P7, P28, and P50) 
and G5 cells.  Sp6 cds: coding region of Sp6; Sp6 endo: 
endogenous Sp6; Sp6 exo: exogenous Sp6.  (C) Epigenetic-
related gene expressions in C9 (P7, P28, and P50) and G5 
cells. 
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Table 1.  Gene Specific Primers
Gene  Primer sequence  
 
18s rRNA  5’CTACCTGGTTGATCCTGCCAGTAGGATC3’  
5’CCCCGTCGGCATGTATTAGCTCTAGAAC3’  
 
Dnmt1  5’CGCTAAGGACGATGATGAGACGCC3’  
5’CCTTTTTGGGTGACGGCAACTCC3’  
 
Dnmt3a  5’CCAGCGTCACACAGAAGCATATCCC3’  
5’CGGTCCTCACTTTGCTGAACTTGGC3’  
 
Dnmt3b  5’CGCAGGAAACCATGAAGGGAGC3’
5’CCCCTCTTAGACAGCCCTGAGC3’
 
LSD1  5’CACACACGCTCCACAAGTCAGC3’  
5’CGCCGACAATCACATCATCAC
 
MeCP2  5’CAGAGGGCAAACATGAACCACC3’  
5’CGAGGTGTCTCCCACCTTTTCC3’  
 
Sp6 cds  5’CCCGGCAATGCTAACCGCTGTCTGTGC3’  
5’CGGCTCAGTTGGAGGACGCCGAGCTGC3’  
Sp6
endogenous  
5’CGCGCCATCTTCAGACCCACC3’  
5’CCCACTTCGCAAGAGGATTTCC3’  
Sp6  
exogenous  
5’CGGCTAGAGTACTTAATACGACTCACC3’
5’CCTCGAAGCATTAACCCTCACTAAAGC3’
 
 
To determine the cause of this reduced express-
ion, we first examined the levels of Sp6 transcripts 
in C9 cells using specific primers to distinguish bet-
ween the three types of Sp6 mRNA: total (coding 
sequence; cds), exogenous, and endogenous Sp6 
mRNAs. We found that the exogenous Sp6 mRNA 
level was remarkably high at P7 and P28 but re-
duced at P50. However, the endogenous Sp6 ex-
pression levels were not changed throughout the 
cell passages (Figure 1B).
Based on these findings, we hypothesized that 
epigenetic mechanisms may have been involved 
in Sp6 transgene expression in C9 cells at P50, 
and we further analyzed the mRNA expression 
levels of  epigenetic-related genes in C9 cells: DNA 
methyltransferase 1 (Dnmt1), DNA methyltransferase 
3a (Dnmt3a), DNA methyltransferase 3b (Dnmt3b), 
methyl-CpG-binding protein-2 (MeCP2), and lysine-
specific demethylase 1 (LSD1)[18-20]. As shown in Figure 
1C, similar expression levels were detected for these 
genes at each passage, except for Dnmt1.  The level 
of Dnmt1 transcripts was decreased at P50 three to 
fourfold compared to the levels at P7 or P28. 
3.2 Responsiveness of C9 cells to 5AC and VPA
To further elucidate the epigenetic regulation of Sp6 
mRNA and SP6 protein expression during long-term 
culture, we treated C9 cells with 5AC and VPA.   Both 
5AC and VPA enhanced or induced the SP6 protein 
expression at P7 and P28 in a dose- and time-
dependent manner (Figures 2A and 2B).  However, 
SP6 protein was not detected in C9 cells at P50 with 
either 5AC or VPA treatment (Figure 2B).  
Next, we examined whether Sp6 mRNA levels 
were enhanced in response to 5AC and VPA (Figure 
2C).  Unexpectedly, we found no dramatic changes 
in the levels of endogenous Sp6 mRNA with either 
reagent.  In contrast, the mRNA level of exogenous 
Sp6 at P50 showed over 3-fold enhancement with 
either 5AC or VPA treatment compared to the 
controls. At P7 and P28, the levels of exogenous Sp6 
mRNA expression showed a tendency to be slightly 
or marginally increased compared to the controls in 
response to both treatments. 
3.3 qPCR analysis of epigenetic-related gene 
expression in response to 5AC and VPA
To investigate whether the selective enhancement 
of Sp6 mRNA expression was correlated with the 
expression of epigenetic-related genes, we analyzed 
their expressions in response to 5AC and VPA.  As 
shown in Figure 3, Dnmt1, Dnmt3a, Dnmt3b, LSD1, 
and MeCP2 expressions were all decreased to 
less than 20% of those in controls at P7 and P28 
in response to 5AC and VPA treatment.  However, 
the responsiveness of these genes to 5AC and VPA 
either disappeared or was reduced at P50, except 
for LSD1. In addition, the basal expression levels of 
these epigenetic-related genes varied among the 
control samples depending on the passage number. 
At P7, basal level expression was maintained during 
treatment, while it increased at P28 and decreased 
at P50. These results indicated that the cellular 
epigenetic status in C9 cells changed along the 
passages. 
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4. Discussion
SP6 is an indispensable factor during tooth 
development9,10. However, the precise role and 
regulation of SP6 remain unclear. Recently, 
we found that SP6 is a short-lived protein and 
specifically degraded by the ubiquitin-independent 
20S proteasome pathway14. Thus, it is suggested 
that SP6 required fine-tuning in vivo to function in a 
time- and space-specific manner. 
Figure 2. Effects of DNMTI and HDACI on Sp6 expression in C9 cells. (A) Dose-dependent effects of 5AC and VPA on SP6 
expression in C9 cells at P7 and P28.  Upper panel: cells were treated with 5AC.  Lower panel: cells were treated with 
VPA.  Posi: positive control; U: no treatment. (B) Time course analysis of 5AC and VPA treatment on SP6 expression in 
C9 cells.  Upper panel: cells were treated with 5AC.  Lower panel: cells were treated with VPA. Posi: positive control. 
(C) Time course analysis of 5AC and VPA treatment on exogenous and endogenous Sp6 mRNAs in C9 cells.  Blue: con-
trol; red: 5AC treatment; green: VPA treatment. 
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Previous reports revealed that DNA methylation 
and histone deacetylation play potential roles in the 
regulation of gene expression21,22. Gene silencing is 
not only strict for endogenous genes but also for 
exogenous DNA that is introduced into mammalian 
cells18,23. The interplay between DNA methylation 
and histone modification is profoundly involved 
and they act synergistically during gene silencing, 
although it is unclear when and which epigenetic 
regulatory mechanism initiates first21,22. In addition, 
it has been reported that the CMV promoter, which 
is frequently used as one of the well-known strong 
mammalian promoters, can be silenced both by 
DNA methylation and histone modification such as 
deacetylation and methylation over time in culture 
18,24,25. 
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Figure 3.  Analysis of epigenetic-related gene expressions. C9 cells at P7, P28, and P50 were treated with either 5AC or VPA for 
the indicated times. mRNA expressions of epigenetic-related genes (Dnmt1, Dnmt3a, Dnmt3b, MeCP2, and LSD1) were analyzed 
by qRT-PCR. Blue: control; red: 5AC treatment; green: VPA treatment. 
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In our study, we demonstrated that SP6 protein 
expression in C9 cells was induced by both DNMTI 
and HDACI treatments at P7 and P28, while only 
exogenous Sp6 mRNA expression was enhanced 
at P50 by both treatments. These findings clearly 
indicated that SP6 protein and its mRNA expression 
were independently regulated in C9 cells by 
mechanisms that were different from the simple 
CMV promoter inactivation by DNA methylation. This 
suggests two important aspects of this regulation. 
First, SP6 protein expression disappeared 
when the level of total Sp6 mRNA started to 
decrease, primarily because of reduced exogenous 
Sp6 mRNA (Figure 1A and 1B). This indicated that 
the translational efficiency was overwhelmed by 
degradation because of the nature of SP6 with a short 
half-life or its high-sensitivity to 20S proteasome 
activity14.  Furthermore, SP6 protein was induced 
but not transcriptionally enhanced at P7 and P28 
by treatments with 5AC and VPA (Figure 2A and 
2B). This suggested effects of DNMTI and HDACI on 
either the translational efficiency of Sp6 mRNA, or 
the sensitivity of the SP6 protein to 20S proteasome 
by SP6 binding proteins as has been shown in the 
case of hypoxia-inducible factor-1α stability, which 
is regulated by recruited HDACI through its binding 
with metastasis-associated protein 126. Although not 
a simple problem, it is a quite interesting issue to 
examine whether SP6 protein stability is controlled 
by protein–protein interactions.
Second, we could not detect any responsiveness 
of endogenous Sp6 mRNA expression to 5AC and VPA 
throughout the cell passages or that of exogenous 
Sp6 mRNA at P7 and P28 (Figure 2C). This finding 
indicated that the chromatin of the endogenous Sp6 
gene locus was opened and that endogenous Sp6 
gene was transcribed at a weak level; however, this 
level was not sufficient to produce a detectable level 
of SP6 protein. Thus, we need to consider several 
regulatory mechanisms, including the balance 
between transcriptional activators and repressors, 
mRNA stability, and translation initiation. In 
addition, a non-coding RNA, such as microRNA, may 
be involved, in which the non-coding RNA may block 
translation by cleaving the abundant exogenous 
Sp6 mRNA or inhibit the translational processes27. 
Because the reciprocal expression of Sp6 mRNA 
and Sp6 opposite strand transcript (Sp6os) has 
been reported to be tissue-specific28, it will be 
interesting to examine whether Sp6os has a role in 
the expression of SP6 protein in C9 cells. 
Furthermore, we also found that the respon-
siveness of epigenetic-related genes to 5AC and 
VPA changed during long-term culture.  In C9 cells 
at P7 and P28, both reagents significantly repressed 
epigenetic-related gene expressions compared 
to controls, while at P50 the levels of these genes 
exhibited no gross changes compared to controls, 
except for LSD1. Because DNA methylation is not 
required for maintenance or establishment of 
the silent chromatin state, the chromatin status 
at P50 was already supposed to be silenced by 
other mechanisms29. Moreover, we observed good 
inhibitory responses of the mRNA expressions of five 
epigenetic regulators to both 5AC and VPA at P28, 
Dewi, et al.
fi
ff
ffi
ff
ffi
fi
ffi
fi
fi
fi
The Indonesian J Dent Res, 2012, Volume 1, No.3 
Published online: http://the-indonesian-jdr.fkg.ugm.ac.id  
 
 
silenced both by DNA methylation and histone 
modification such as deacetylation and 
methylation over time in culture [18,24,25].  
In our study, we demonstrated that SP6 
protein expression in C9 cells was induced by both 
DNMTI and HDACI treatments at P7 and P28, 
while only exogenous Sp6 mRNA expression was 
enhanced at P50 by both treatments. These 
findings clearly indicated that SP6 protein and its 
mRNA expression were independently regulated 
in C9 cells by mechanisms that were different 
from the simple CMV promoter inactivation by 
DNA methylation. This suggests two important 
aspects of this regulation.  
       First, SP6 protein expression disappeared 
when the level of total Sp6 mRNA started to 
decrease, primarily because of reduced exogenous 
Sp6 mRNA (Figure 1A and 1B). This indicated that 
the translational efficiency was overwhelmed by 
degradation because of the nature of SP6 with a 
short half-life or its high-sensitivity to 20S 
proteasome activity [14].  Furthermore, SP6 
protein was induced but not transcriptionally 
enhanced at P7 and P28 by treatments with 5AC 
and VPA (Figure 2A and 2B). This suggested effects 
of DNMTI and HDACI on either the translational 
efficiency of Sp6 mRNA, or the sensitivity of the 
SP6 protein to 20S proteas me by SP6 bindi g 
proteins as has been shown in the case of 
hypoxia-inducible factor-1α stability, which is 
regulat d by recruited HDACI through its binding 
with metastasis-associat d protein 1 [26]. 
Although not a simple problem, it is  quite 
interesting issue to examine whether SP6 protein 
stability is controlled by protein–protein 
i teractions. 
       Second, we could not et ct any 
r sponsiveness of endogenous Sp6 mRNA 
xpression o 5AC and VPA throughou  th  cell 
passages or that of exogenous Sp6 mRNA at P7 
and P28 (Figure 2C). This finding indicated that 
the chromatin of the endogenous Sp6 gene locus 
was opened and that endogenous Sp6 gene was 
transcribed at a weak level; however, this level 
was not sufficient to produce a detectable level of 
SP6 protein. Thus, we need to consider several 
regulatory mechanisms, including the balance 
between transcriptional activators and repressors, 
 
 
Figure 4 Working model of the C9 cell status leading to 
silencing of exogenous Sp6 gene during long-term culture. 
Detailed description of this model is in the Discussion. CMV: 
cytomegalovirus promoter; red circle: methylated CpG; blue 
rectangle: deacetylated histone. 
 
mRNA stability, and translation initiation. In 
addition, a non-coding RNA, such as microRNA, 
may be involved, in which the non-coding RNA 
may block translation by cleaving the abundant 
exogenous Sp6 mRNA or inhibit the translational 
processes [27]. Because the reciprocal expression 
of Sp6 mRNA and Sp6 opposite strand transcript 
(Sp6os) has been reported to be tissue-specific 
[28], it will be interesting to examine whether 
Sp6os has a role in the expression of SP6 protein 
in C9 cells.  
       Furthermore, we also found that the 
responsiveness of epigenetic-related genes to 5AC 
and VPA changed during long-term culture.  In C9 
c lls at P7 and P28, both reagents sig ific ntly 
repressed epigenetic-relat  gen  expressions 
compared to controls, whil  at P50 the levels of 
t ese gen s exhibited no gross change  compared 
to controls, excep  for LSD1. Because DNA 
Figure 4 Working model of the C9 cell status leading to si-
lencing of exogenous Sp6 gene during long-term culture. 
Detailed description of this model is in the Discussion. 
CMV: cytomegalovirus promoter; red circle: methylated 
CpG; blue rectangle: deacetylated histone.
Figure 4. Working model of the C9 cell status leading to 
silencing of exogenous Sp6 gene during long-t rm cul-
ture. Detailed description of this model is in the Disc s-
sion. CMV: cytomegalovirus promoter; red ircle: meth-
ylated CpG; bl e rectangle: deacetylat d histone.
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suggesting that C9 cells have epigenetic plasticity 
during long-term culture.    
Taken together, we conclude that epigenetic 
regulation is involved in Sp6 transgene expression 
in C9 cells.  Based on our findings, we have hypo-
thesized a working model that indicates the 
stepwise changes in cellular competency to activate 
Sp6 transgene expression in C9 cells; this model 
is outlined in Figure 4.  During early passage (P7), 
the CMV promoter is weakly methylated but does 
not affect the transcriptional processes to a great 
extent. Therefore, strongly enhanced Sp6 mRNA 
is translated into SP6 protein and acts to regulate 
the target genes. Some parts of the SP6 protein 
pool are degraded by a proteasome pathway as 
shown previously14. During a middle passage (P28), 
moderate methylation of the CMV promoter region 
is implicated in the repression of Sp6 transcription, 
resulting in SP6 protein degradation.  At a later 
passage (P50), hypermethylation of the CMV 
promoter region occurs upon long-term culture, 
which results in a limited copy number of Sp6 
transcripts being translated and most of the SP6 
protein products are degraded by a proteasome 
pathway. 
5. Conclusion
We investigated the molecular mechanisms 
underlying Sp6 regulation through transgene 
silencing detected in Sp6 stable transformant C9 
cells. Our findings provide new insights to analyze 
the regulation of SP6 during the developmental 
stages and its tissue-specificity in vivo.
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